(CNN)A King County, Washington, woman has died from a rare blood clotting syndrome after receiving the Johnson & Johnson Covid-19 vaccine, according to a statement posted online by Public Health — Seattle & King County.
The woman, who was in her late 30s, was vaccinated on August 26 and died on September 7 from thrombosis with thrombocytopenia syndrome, known as TTS. It’s a rare and potentially deadly clotting event that has been linked with the J&J vaccine.
Officials said the diagnosis was confirmed by the US Centers for Disease Control and Prevention’s Clinical Immunization Safety Assessment Project. CDC has reported three other confirmed TTS deaths nationally, the release said.
A spokesperson at J&J told CNN:
“The safety and well-being of every individual who receives a Johnson & Johnson product remains our top priority.
“Any adverse event report about individuals receiving Johnson & Johnson’s single-shot COVID-19 vaccine, as well as our own assessment of the report, is shared with the U.S. Food and Drug Administration (FDA), European Medicines Agency, the World Health Organisation (WHO) and other appropriate health authorities where our vaccine is authorized.
“We strongly support raising awareness of the signs and symptoms of the rare events described in the FDA Factsheet for the vaccine, to ensure they can be quickly identified and effectively treated.”
The local health agency did not identify the woman who died. But early this month, the website of The Oregonian newspaper published an obituary for 37-year-old Seattle resident Jessica Berg Wilson that said she died September 7 from a rare vaccine-induced blood clotting syndrome.
The King County Medical Examiner’s Office confirmed to CNN that Wilson died September 7.
In a statement, the CDC said it was aware of the case and the report “indicates a plausible causal relationship between the J&J/Janssen COVID-19 Vaccine and TTS.” The agency said it will release updated information on TTS cases later this year.
Earlier this year, the CDC and US Food and Drug Administration recommended a pause in the use of the J&J Covid-19 vaccine after a small number of reports of blood clots … READ MORE.
